Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, TG Therapeutics Inc’s stock clocked out at $28.08, up 1.12% from its previous closing price of $27.77. In other words, the price has increased by $1.12 from its previous closing price. On the day, 1.81 million shares were traded. TGTX stock price reached its highest trading level at $28.35 during the session, while it also had its lowest trading level at $27.64.
Ratios:
To gain a deeper understanding of TGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 3.86. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.91.
On October 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $50.
Goldman Upgraded its Sell to Neutral on August 02, 2023, whereas the target price for the stock was revised from $16 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 13 ’25 when Echelard Yann sold 10,000 shares for $36.94 per share. The transaction valued at 369,400 led to the insider holds 228,816 shares of the business.
Echelard Yann bought 10,000 shares of TGTX for $369,348 on Jun 13 ’25. On Jan 03 ’25, another insider, Power Sean A, who serves as the CFO of the company, sold 11,337 shares for $30.29 each. As a result, the insider received 343,443 and left with 670,632 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4455341056 and an Enterprise Value of 4099401984. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 75.04, and their Forward P/E ratio for the next fiscal year is 16.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.81 while its Price-to-Book (P/B) ratio in mrq is 16.05. Its current Enterprise Value per Revenue stands at 9.028 whereas that against EBITDA is 47.729.
Stock Price History:
The Beta on a monthly basis for TGTX is 1.88, which has changed by 0.11472809 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, TGTX has reached a high of $46.48, while it has fallen to a 52-week low of $20.81. The 50-Day Moving Average of the stock is -20.23%, while the 200-Day Moving Average is calculated to be -18.06%.
Shares Statistics:
It appears that TGTX traded 2.01M shares on average per day over the past three months and 3962710 shares per day over the past ten days. A total of 158.03M shares are outstanding, with a floating share count of 142.90M. Insiders hold about 9.93% of the company’s shares, while institutions hold 63.95% stake in the company. Shares short for TGTX as of 1753920000 were 23442551 with a Short Ratio of 11.68, compared to 1751241600 on 24062667. Therefore, it implies a Short% of Shares Outstanding of 23442551 and a Short% of Float of 19.43.
